The current PKPH market cap is 121.46M. The company's latest EPS is USD -0.0021 and P/E is -738.10.
Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -28k | -6k | -6k | -69k | -163k |
Net Income | -28k | -14k | -15k | -76k | -165k |
Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2k | 1,000 | 0 | 261k | 130k |
Total Liabilities | 223k | 236k | 250k | 587k | 621k |
Total Equity | -221k | -235k | -250k | -326k | -491k |
Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -44k | -1,000 | -1,000 | -14k | -68k |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 43k | N/A | N/A | 275k | -65k |
Market Cap | 121.46M |
Price to Earnings Ratio | -738.10 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 968.75 |
Price to Book Ratio | -247.38 |
Dividend Yield | - |
Shares Outstanding | 78.36M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -44.84% |
52 Week High | 4.50 |
52 Week Low | 1.37 |
Spread (Intraday) | 1.03 (39.77%) |
Company Name | Peak Pharmaceuticals Inc (PK) |
Address |
14201 n. hayden road, suite a-1, scottsdale, az 85260 |
Website | https://www.peakpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.